Dr. Zhenfu Fu 傅真富
Chief Physician
Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Clinical diagnosis and radiochemotherapy for tumors, with a focus on head and neck malignancies such as nasopharyngeal, tonsil, tongue, and laryngeal cancers, central nervous system tumors, and unexplained neck masses.
Dr. Fu is a Chief Physician in the Department of Radiation Oncology and Head of Ward 212 West at Zhejiang Cancer Hospital. Since 1986, Dr. Fu has worked in tumor radiochemotherapy, focusing on the diagnosis and comprehensive treatment of head and neck malignancies and interpreting CT and MRI images.
Name order: in Chinese the family name comes first (Fu Zhenfu). Papers usually list the name as Zhenfu Fu or Fu Z.
Selected publications
26 papers on PubMed matched by name and affiliation; 6 as first or senior author since 2016. Most recent first- or senior-author papers:
- Biosci Rep, 2020 (senior author): Bioinformatics-based analysis of the lncRNA-miRNA-mRNA and TF regulatory networks reveals functional genes in esophageal squamous cell carcinoma. PubMed 32662828
- Radiat Oncol, 2019 (senior author): ADC correlation with Sirtuin1 to assess early chemoradiotherapy response of locally advanced esophageal carcinoma patients. PubMed 31684999
- Arch Oral Biol, 2019 (senior author): Identification of candidate genes of nasopharyngeal carcinoma by bioinformatical analysis. PubMed 31319350
- World J Surg Oncol, 2019 (senior author): Bioinformatic identification of candidate biomarkers and related transcription factors in nasopharyngeal carcinoma. PubMed 30935420
- J Cell Biochem, 2018 (senior author): Doxorubicin-loaded poly(ε-caprolactone)-Pluronic micelle for targeted therapy of esophageal cancer. PubMed 30256436
- Oncotarget, 2017 (senior author): Efficacy and safety of nimotuzumab with neoadjuvant chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma. PubMed 29088889
- Head Neck, 2015 (senior author): Effect of number and ratio of positive lymph nodes in hypopharyngeal cancer. PubMed 24347492
- Zhonghua Zhong Liu Za Zhi, 2014 (senior author): [Prognostic significance of the number of positive lymph nodes, number of involved regions and metastatic lymph node ratio in hypopharyngeal cancer]. PubMed 25567312
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion